Kane Biotech Inc Ord (KNBIF) Q2 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Kane Biotech Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.009 -- 00:00:04.271 Parties will be in a listen-only mode. Following the presentation, the conference call 00:00:04.271 -- 00:00:09.354 will be open to questions. If you have a question, please press star, then 1-1 on your 00:00:09.354 -- 00:00:13.797 touchtone phone. If you would like to withdraw your question, please press star, 1-1 00:00:13.797 -- 00:00:17.239 again. This conference is being recorded today, August 29th, 2024. 00:00:17.239 -- 00:00:22.241 I would now like to turn the conference over to Ray DuPois, 00:00:22.241 -- 00:00:27.363 Kean Biotech's Chief Financial Officer. Please go ahead. 00:00:28.025 -- 00:00:32.753 Thank you, Operator. Good afternoon and welcome everyone to CAEN Biotech's second quarter 00:00:32.753 -- 00:00:38.285 2024 earnings conference call. We are delighted to have you join us today. 00:00:38.285 -- 00:00:42.347 This call will cover CAEN's financial and operating results, along with a discussion 00:00:42.347 -- 00:00:47.349 of some of our recent highlights and goals for the range of 2024 and beyond. 00:00:47.349 -- 00:00:51.090 Following our prepared remarks, we will open the conference call to a question and answer 00:00:51.090 -- 00:00:56.852 session. Our call today will be led by CAEN's Chief Executive Officer, Mark Edwards. 00:00:56.852 -- 00:01:01.077 Before we begin our formal remarks, I would like to remind everyone that some of the 00:01:01.077 -- 00:01:06.118 statements on this conference call contain certain forward-looking information and statements 00:01:06.118 -- 00:01:11.079 within the meaning of securities law, which may not be based on historical fact, including 00:01:11.079 -- 00:01:16.800 without limitation statements containing the words believes, should, may, 00:01:16.800 -- 00:01:21.921 plan, wi...